Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor.
about
Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the DiseaseThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsTransforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cellsBET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis.Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.MicroRNA binding site polymorphisms as biomarkers in cancer management and research.Interleukin-17 Indirectly Promotes M2 Macrophage Differentiation through Stimulation of COX-2/PGE2 Pathway in the Cancer Cells.The prognostic value of liver tumor T cell infiltratesPrognostic significance of interleukin 17 in cancer: a meta-analysis.Plasticity of γδ T Cells: Impact on the Anti-Tumor ResponseIL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer TherapyCDDO-Me Redirects Activation of Breast Tumor Associated Macrophages.Prognostic significance of interleukin-17 in solid tumors: a meta-analysis.Multiple cells express interleukin 17 in oral squamous cell carcinoma.Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence.IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions.Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis.Interleukin-17 and type 17 helper T cells in cancer management and research.IL-17A-producing T cells are associated with the progression of lung adenocarcinomaIL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.Harnessing the immune system for the treatment of breast cancer.Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancerInterleukin-8 and interleukin-17 for cancer.Role of IL-17 in Glioma ProgressionThe role of the mediators of inflammation in cancer development.IL-2 Shapes the Survival and Plasticity of IL-17-Producing γδ T Cells.Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development.Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different.Systemic inflammation: Cancer's long-distance reach to maximize metastasis.Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients.Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages.TLR5 signaling, commensal microbiota and systemic tumor promoting inflammation: the three parcae of malignant progression.Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis.The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review.Infiltration of γδ T cells, IL-17+ T cells and FoxP3+ T cells in human breast cancer.CD4 and CD8 T lymphocyte interplay in controlling tumor growth.
P2860
Q26771264-2A401267-B1EC-458E-9CF2-BD2E96E22801Q26799120-AF259559-4C86-42AF-983D-CA594E8FFF27Q26996742-48C71270-A2E5-425D-8839-4C860081B4B7Q30248629-B9DC0048-80E6-4928-9321-465E7F5F6DA7Q33776130-C1B32589-844A-47EF-85A8-7A5039DD04B7Q34009975-E57E909A-F57C-4AD7-87B9-71C628E91999Q34019040-93800215-E626-4707-8EFD-1853B34DD943Q34043416-E3E53A4F-D90C-417D-91F0-735AEB519C0DQ34052611-EE7FDE2E-4E13-4EB5-B4E4-3BF4F3B8786DQ34547722-4FE90181-7CF1-4BC6-BA4C-64A694B65475Q34652408-6EE9C7FC-6B08-4100-942F-84A6721683CBQ35763387-E084F589-AEF0-44B3-8D57-7FCB75B7CD1DQ35826624-DEEE62EB-F2F5-49D1-8557-022F60C2EE4FQ35937008-A0086A9B-5110-4D56-8C6F-E111AC7E917CQ36046142-92264F97-DD1D-4398-A340-43BF7E315125Q36050163-D2C02F23-049F-44CF-9F2A-E7B7E4CFB1D8Q36198776-20E97A67-CFCC-4714-A778-749A4B658E94Q36228470-3BD06D4F-B208-4F35-B8A9-57DB14C613F9Q36288515-0D8B04AB-0AE9-4699-95E6-50752D826041Q36597320-3229185D-2299-449C-AA44-71C3409BCCCAQ36772903-5D567620-B26F-47D2-8CAF-65563B6C2F58Q37031654-6971953E-6EA6-411C-A05D-B015426E116EQ37066685-3E85A1C7-C5E4-45CB-AA60-432AC217788BQ37376363-63A13738-70BB-484D-AD31-4D031CC25826Q37476039-CFCED8F5-536C-461B-AA44-ED5BA3E5B438Q37702580-9AD8B719-C997-4224-BCE5-11D9F54E7876Q38199524-4FA5F795-05DB-4CF3-B23B-45777AF4E485Q38270824-745D29C4-4E10-4521-AE27-BFE45F8D85DDQ38367696-9DF86927-7657-4C18-AF55-CF7FB1276F83Q38611201-DBAA5D97-C411-4197-ABDF-0C835DE195E4Q38726934-49BAF61E-B329-48EE-B85F-BC2300ACBF19Q38975039-9B3DA8CC-5D4A-4B9D-9F76-23070C9C4106Q39279591-2C018536-BCEB-4582-8FF1-AC36877E9D97Q40216038-8B6D2205-D0D7-4743-AB74-34C68EB8FA9EQ41338881-F9238BC8-882D-4D46-ADA3-6FB01D552909Q41865756-D19C0F50-E36D-4A09-A8F7-D0E9294A3B0CQ42371641-37203ED5-556E-4503-BCFF-34DBF072E2DAQ42600273-F1E1E205-E422-4849-AFD8-B9563CDD0A19Q47737173-C93D352A-EE68-44FC-B965-0D280EDEBEBDQ48185876-FEF6A48C-BCC4-41F1-B425-414472A434B4
P2860
Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Interleukin-17-producing cell ...... t is a poor prognostic factor.
@en
Interleukin-17-producing cell ...... t is a poor prognostic factor.
@nl
type
label
Interleukin-17-producing cell ...... t is a poor prognostic factor.
@en
Interleukin-17-producing cell ...... t is a poor prognostic factor.
@nl
prefLabel
Interleukin-17-producing cell ...... t is a poor prognostic factor.
@en
Interleukin-17-producing cell ...... t is a poor prognostic factor.
@nl
P2093
P2860
P356
P1433
P1476
Interleukin-17-producing cell ...... nt is a poor prognostic factor
@en
P2093
Helen H W Chen
Hung-Yu Chen
Wen-Chung Chen
Yu-Hsuan Lai
P2860
P304
P356
10.1111/HIS.12156
P577
2013-06-06T00:00:00Z